| 摘要 |
<p num="1"><br/><br/><br/>Disclosed herein are methods for diagnosing or treating pregnancy related <br/>hypertensive disorders that include the use of a polypeptide or a nucleic acid <br/>encoding a polypeptide selected from the following: follistatin related <br/>protein, interleukin 8, inhibin A, VEGF-C, angiogenin, beta fertilin, <br/>hypothetical protein, leukocyte associated Ig-like receptor secreted protein, <br/>erythroid differentiation protein, adipogenesis inhibitory factor, <br/>corticotropin releasing factor binding protein, alpha-1- anti-chymotrypsin, <br/>insulin-like growth factor binding protein-5, CD33L, cytokine receptor like <br/>factor 1, platelet derived endothelial growth factor, lysyl hydroxylase <br/>isoform 2, stanniocalcin precursor, secreted frizzled related protein, <br/>galectin-3, alpha defensin, ADAM-TS3, cholecystokinin precursor, interferon <br/>stimulated T-cell alpha chemoattractant precursor, azurocidin, sperminine <br/>oxidase, UDP glycosyltransferase 2 family polypeptide B28, neurotrophic <br/>tyrosine kinase receptor 2, neutral endopeptidase, CDC28 protein kinase <br/>regulatory subunit 2, beta glucosidase, lanosterol synthase, <br/>calcium/calmodulin-dependent serine protein kinase, estrogen receptor-<br/>alternatively spliced transcript H, chemokine (CX3C motif) receptor 1, <br/>tyrosinase-related protein 1, hydoxy-delta-5-steroid dehyrogenase, <br/>dihydropyramidinase-like-4, and cytochrome P450-family 11.<br/> |
